Sponsors (9)
The bill increases scientific standards, transparency, and (with funding) the speed of federal vaccine recommendation processes—likely improving access and predictability—while constraining executive discretion, imposing tight deadlines and a high evidentiary bar that could delay certain updates, raise litigation risk, and create perceptions of stakeholder influence.
Children and adolescents eligible for the Vaccines for Children (VFC) program will have clearer statutory immunization schedules for VFC purchasing and coverage, improving vaccine access for eligible kids.
Patients (including those with chronic conditions), children, and health systems will get faster consideration and potentially quicker access to newly licensed vaccines and new indications because ACIP recommendations must be considered at the next regular meeting and a 90‑day recommendation deadline is imposed; the bill also authorizes funding to support ACIP operations.
Clinicians, hospitals, and vaccine claimants will face Vaccine Injury Table and vaccine-policy changes governed by a required 'preponderance of the best available, peer‑reviewed evidence,' increasing scientific rigor and predictability for which injuries are compensable.
Taxpayers will fund an authorized appropriation of about $2.8M per year (FY2026–2029), adding to federal budget demands.
Patients (including those with chronic conditions) and providers face the risk that the 90‑day statutory deadline for ACIP recommendations will pressure deliberations and could produce rushed or less-thorough guidance on complex or uncertain evidence.
Hospitals, health systems, and the Secretary may have reduced policy flexibility because the Director is required to adopt ACIP recommendations unless they fail the specified preponderance standard, limiting consideration of implementation, cost, or other non‑scientific factors.
Based on analysis of 3 sections of legislative text.
Codifies ACIP into statute, requires recommendations and Vaccine Injury Table changes be supported by a preponderance of peer‑reviewed scientific evidence, and imposes deadlines and publication/notification rules.
Introduced December 3, 2025 by John Wright Hickenlooper · Last progress December 3, 2025
Codifies the Advisory Committee on Immunization Practices (ACIP) into statute, requires ACIP advice to the CDC Director to be based on a preponderance of the best available, peer‑reviewed scientific evidence, and limits how the Secretary may remove or modify entries on the Vaccine Injury Table by requiring similar evidentiary support. The bill also imposes procedural requirements on the CDC Director to adopt ACIP recommendations unless not supported by that standard, to publish decisions and notifications, and sets timelines for ACIP consideration of newly licensed vaccines and responses to vaccine manufacturers.